Company / R&D per Share
Doximity R&D per Share History
FY2019-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.43
FY2026
5-year range
$0.39 / $0.69
FY2022-FY2026
Trend
-37.3%
vs FY2025
Sector context
#91 of 109
Health Care
What the data says
Doximity's r&d per share of $0.43 is lower than 83% of companies in the Health Care sector (FY2026). R&D per Share has fluctuated over the past 8 years, ranging from $0.33 in FY2021 to $0.69 in FY2025.
Based on SEC 10-K filings.
0.43 in FY2026 with a 5-year CAGR of +5.9%.
Declined from $0.50 to $0.43 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +0.9%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 109This company $0.43 Sector average $2.08
▼
-79.1% below sector average
Key checks
Key Insights
- In FY2026, r&d per share decreased 37.3% year-over-year.
- Ranks #91 out of 109 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2025.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $0.43 | -37.3% |
| FY2025 | $0.69 | +38.8% |
| FY2024 | $0.50 | +18.0% |
| FY2023 | $0.42 | +8.1% |
| FY2022 | $0.39 | +19.9% |
| FY2021 | $0.33 | -29.2% |
| FY2020 | $0.46 | +16.2% |
| FY2019 | $0.40 | - |
As of FY2026 · SEC 10-K · Updated Jul 2, 2026